Company: ZURA
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001104659-25-038042
Chunk: 30

Company: Zura Bio Ltd
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 30
---
 in today’s business environment; (ii) understanding of the Company’s business on a technical level; and (iii) educational and professional background; and (iv) a diversity of skills, experience, background and perspective. Generally, our Nominating and Governance Committee identifies candidates for director nominees in consultation with management, using search firms or other advisors, through the recommendations submitted by shareholders or through such other methods as the Nominating and Governance Committee deems to be helpful to identify candidates. The Nominating and Governance Committee may review, screen and evaluate the qualifications of qualified director nominees and then selects a nominee for recommendation to the Board by majority vote. Our Nominating and Governance Committee’s priority in selecting board members is identification of persons who will further the interests of the Company through his or her established record of professional accomplishment, the ability to contribute positively to the collaborative culture among members of the board, and professional and personal experiences and expertise relevant to our growth strategy. Shareholder Recommendations The Nominating and Governance Committee will consider written recommendations from shareholders for director candidates. The Nominating and Governance Committee considers persons recommended by our shareholders in the same manner as a nominee recommended by our Board members, management or a third-party executive search firm in accordance with the criteria described above. The Nominating and Governance Committee evaluates candidates recommended by shareholders using the same criteria it applies to evaluate other candidates. Shareholders who wish to recommend a director candidate should submit the candidate’s name and background information in writing to our Corporate Secretary at 1489 W. Warm Springs Rd. #110, Henderson, Nevada 89014. Nominating shareholders and nominees must satisfy the requirements set forth in our MAA. Any notice of director nomination submitted to Zura must comply with any additional requirements of Rule 14a-19(b) under the Exchange Act. 16 TABLE OF CONTENTS Research and Development Committee The Board has also established a Research and Development Committee. As of the date of this Proxy Statement, the Research and Development Committee consists of Neil Graham, Sandeep Kulkarni and Arnout Ploos van Amstel, with Neil Graham serving as chair of the committee. Specific responsibilities of the Research and Development Committee include: • reviewing and providing scientific advice for the Company’s research and development programs; • providing advice to the Board regarding the strategic direction of the Company’s research and development activities; • identifying and discussing significant emerging trends and issues in science and technology and considering the potential impact of such on the Company’s research and development; and • providing